Skip to content

Author

Li-Ming Chen

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Evaluation of EVT401, a P2X7 Receptor Antagonist, in Healthy Chinese Participants: a first-in-human, double-blind, randomized, placebo-controlled, dose-escalation trial.

PURPOSE As a critical hub between extracellular danger signals and intracellular inflammation, the P2X7 receptor centrally drives synovitis and joint destruction in rheumatoid arthritis, making it an attractive therapeutic target. This study reported the first-in-human data for EVT401, an orally administered P2X7 recep...

Hai-Mei Xu, Li-Ming Chen, Hai-Yan Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.